SIM 5 Jessica Whitaker Vaginal Odor: activity report:
Women's Health GYN | 2026 update | 100% correct
-American Sentinel University.
1. A 30-year-old woman reports a fishy vaginal odor for 3 days, no itching or discharge. On
exam, thin gray-white discharge is noted, and the pH is 5.5. Whiff test is positive. Which of
the following is the most appropriate initial pharmacotherapy according to 2026 CDC
guidelines?
A. Metronidazole 500 mg orally twice daily for 7 days
B. Clindamycin 2% cream intravaginally at bedtime for 7 days
C. Tinidazole 2 g orally single dose
D. Metronidazole 0.75% gel intravaginally once daily for 5 days
Answer: A
Rationale: For symptomatic bacterial vaginosis, the 2026 CDC recommends oral metronidazole
500 mg BID for 7 days as first-line due to superior efficacy over topical options. Clindamycin
cream is alternative but less effective. Tinidazole is second-line. Metronidazole gel is also
effective but oral route is preferred for adherence.
2. In a patient with recurrent bacterial vaginosis (3 episodes in 12 months), which
management strategy is recommended based on 2026 evidence?
A. Treat with metronidazole gel for 10 days, then initiate suppressive therapy with metronidazole gel
twice weekly for 4-6 months
B. Single-dose oral tinidazole plus intravaginal boric acid for 21 days
C. Treat each recurrence with a 7-day course of clindamycin cream
D. Refer to infectious disease specialist for intravenous antibiotics
Answer: A
Rationale: For recurrent BV, suppressive therapy with metronidazole gel twice weekly after initial
treatment reduces recurrence. Boric acid is used for refractory cases but not first-line. Treating
each episode alone does not prevent recurrence. IV antibiotics are not indicated.
3. A woman presents with vaginal odor and frothy yellow-green discharge. On wet mount,
motile trichomonads are seen. She has a history of metronidazole allergy (urticaria). What
is the recommended treatment?
A. Tinidazole 2 g orally single dose with desensitization if needed
B. Clindamycin 300 mg orally twice daily for 7 days
C. Metronidazole 2 g orally single dose under observation
Page 1
,D. Intravaginal paromomycin cream for 14 days
Answer: A
Rationale: Tinidazole is the alternative for trichomoniasis in metronidazole allergy, but
cross-reactivity is possible; desensitization may be needed. Clindamycin is ineffective for
trichomoniasis. Paromomycin is reserved for resistant cases. Metronidazole is contraindicated
due to allergy.
4. Which of the following best explains the mechanism by which bacterial vaginosis
increases susceptibility to HIV acquisition?
A. Reduction in vaginal Lactobacillus species leads to increased vaginal pH and loss of hydrogen
peroxide, which normally inactivates HIV
B. Anaerobic bacteria produce proteases that degrade the HIV envelope
C. BV-associated bacteria induce a robust Th1 response that recruits CD4+ T cells to the mucosa
D. Elevated pH enhances HIV reverse transcriptase activity
Answer: A
Rationale: In BV, loss of hydrogen peroxide-producing lactobacilli reduces the innate antiviral
barrier, and increased pH and biofilm facilitate HIV survival. Option C is incorrect because BV
actually reduces protective lactobacilli and may increase target cells, but the primary
mechanism is loss of hydrogen peroxide. Options B and D are not established.
5. A patient with vaginal odor has a negative wet mount and negative nucleic acid
amplification test (NAAT) for trichomonas and chlamydia/gonorrhea. She is sexually active
with a male partner who is asymptomatic. Which of the following is the most likely cause of
her symptoms?
A. Cytolytic vaginosis
B. Atrophic vaginitis
C. Desquamative inflammatory vaginitis
D. Aerobic vaginitis
Answer: D
Rationale: Aerobic vaginitis presents with vaginal odor, discharge, and inflammation, often with
negative tests for STIs and BV. It is characterized by aerobic bacteria (e.g., Group B
Streptococcus, E. coli). Cytolytic vaginosis causes burning and dyspareunia, not odor. Atrophic
vaginitis occurs with estrogen deficiency. Desquamative inflammatory vaginitis is a severe form
of aerobic vaginitis but less common.
6. In a patient with persistent vaginal odor despite multiple courses of antibiotics, which of
the following diagnostic tests is most appropriate to evaluate for non-infectious causes?
A. Vaginal biopsy for histology
B. High-resolution anoscopy
C. Colposcopy with acetic acid
Page 2
,D. MRI of the pelvis
Answer: A
Rationale: Vaginal biopsy can diagnose conditions like desquamative inflammatory vaginitis,
lichen planus, or malignancy. High-resolution anoscopy is for anal lesions. Colposcopy is for
cervical evaluation. MRI is not indicated for vaginal odor without other findings.
7. A woman with recurrent BV is interested in probiotic prophylaxis. Based on 2026
evidence, which statement about probiotics is most accurate?
A. Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 have demonstrated efficacy in
reducing BV recurrence when used as adjunct to antibiotics
B. Probiotics are contraindicated in immunocompetent women due to risk of bacteremia
C. Intravaginal probiotic suppositories are superior to oral probiotics for preventing BV recurrence
D. Probiotics alone are as effective as metronidazole for treatment of acute BV
Answer: A
Rationale: Evidence supports oral Lactobacillus strains GR-1 and RC-14 as adjuncts to reduce
BV recurrence. Option B is false; probiotics are safe in immunocompetent women. Option C: no
clear superiority of intravaginal over oral. Option D: probiotics are not recommended as
monotherapy for acute BV.
8. A 25-year-old woman with vaginal odor and discharge is found to have bacterial
vaginosis on wet mount. She is currently taking oral contraceptives. Which of the following
is true regarding the interaction between BV treatment and her contraception?
A. Metronidazole may reduce the efficacy of oral contraceptives, requiring backup contraception
B. Clindamycin cream may weaken latex condoms, but not oral contraceptives
C. Tinidazole has no effect on oral contraceptive metabolism
D. Antibiotics for BV do not affect oral contraceptive efficacy, with the exception of rifampin
Answer: D
Rationale: Current evidence indicates that most antibiotics, including metronidazole and
clindamycin, do not reduce oral contraceptive efficacy. Rifampin is the only antibiotic known to
induce hepatic enzymes and reduce efficacy. Options A and C are incorrect. Option B is true for
oil-based vaginal products but not specifically for clindamycin cream.
9. In the management of trichomoniasis, which of the following is a recommended step to
ensure partner treatment and reduce reinfection?
A. Expedited partner therapy (EPT) with a prescription for the partner without examination
B. Require partner to be examined and treated by a clinician
C. Advise patient to abstain from sex until both partners are treated, but no partner treatment is
necessary if asymptomatic
D. Treat only the patient and recommend partner testing only if symptoms develop
Answer: A
Page 3
, Rationale: Expedited partner therapy (EPT) is recommended for trichomoniasis to reduce reinfection rates. Option B is not
required; EPT is effective. Option C is incorrect because asymptomatic male partners often carry the infection. Option D
leads to high reinfection risk.
10. A patient with vaginal odor has a positive NAAT for Trichomonas vaginalis. She is
pregnant (first trimester). What is the recommended treatment?
A. Metronidazole 2 g orally single dose (avoid in first trimester)
B. Tinidazole 2 g orally single dose (preferred in pregnancy)
C. Clindamycin 300 mg orally twice daily for 7 days
D. Metronidazole 500 mg orally twice daily for 7 days
Answer: D
Rationale: The 2026 CDC recommends metronidazole 500 mg BID for 7 days for trichomoniasis
in pregnancy, even in first trimester, as it is safe. Option A is incorrect because single-dose
metronidazole is less effective. Tinidazole is not recommended in pregnancy. Clindamycin is
ineffective for trichomoniasis.
11. A 30-year-old woman with no significant medical history presents with a 3-day history
of malodorous vaginal discharge, pruritus, and burning on urination. She is sexually active
with one male partner and uses condoms inconsistently. On speculum exam, there is a thin,
homogeneous, gray-white discharge with a fishy odor. A wet mount shows clue cells. Which
of the following pathophysiological mechanisms is most directly responsible for the
characteristic odor in this condition?
A. Overgrowth of Lactobacillus species producing excess lactic acid
B. Production of polyamines by anaerobic bacteria such as Gardnerella vaginalis
C. Release of prostaglandins from disrupted epithelial cells
D. Activation of histamine release from mast cells in the vaginal mucosa
Answer: B
Rationale: The fishy odor in bacterial vaginosis (BV) is due to the production of polyamines (e.g.,
putrescine, cadaverine) by anaerobic bacteria, which become volatile when alkalinized (e.g., by
the KOH whiff test). Option A is incorrect because Lactobacillus normally produces lactic acid,
which is protective, and its decrease is associated with BV. Option C is associated with
prostaglandins in menstruation, not odor. Option D describes an allergic or inflammatory
response, not characteristic of BV.
12. A 25-year-old woman with recurrent bacterial vaginosis (BV) is considering long-term
suppressive therapy. She has had three episodes in the past year. According to the 2021
CDC STI Treatment Guidelines, which of the following regimens is recommended for
suppressive therapy in women with recurrent BV?
A. Metronidazole vaginal gel 0.75% once weekly for 4 months
B. Metronidazole 500 mg orally twice daily for 7 days each month
C. Clindamycin ovules 100 mg intravaginally once daily for 10 days
Page 4
Women's Health GYN | 2026 update | 100% correct
-American Sentinel University.
1. A 30-year-old woman reports a fishy vaginal odor for 3 days, no itching or discharge. On
exam, thin gray-white discharge is noted, and the pH is 5.5. Whiff test is positive. Which of
the following is the most appropriate initial pharmacotherapy according to 2026 CDC
guidelines?
A. Metronidazole 500 mg orally twice daily for 7 days
B. Clindamycin 2% cream intravaginally at bedtime for 7 days
C. Tinidazole 2 g orally single dose
D. Metronidazole 0.75% gel intravaginally once daily for 5 days
Answer: A
Rationale: For symptomatic bacterial vaginosis, the 2026 CDC recommends oral metronidazole
500 mg BID for 7 days as first-line due to superior efficacy over topical options. Clindamycin
cream is alternative but less effective. Tinidazole is second-line. Metronidazole gel is also
effective but oral route is preferred for adherence.
2. In a patient with recurrent bacterial vaginosis (3 episodes in 12 months), which
management strategy is recommended based on 2026 evidence?
A. Treat with metronidazole gel for 10 days, then initiate suppressive therapy with metronidazole gel
twice weekly for 4-6 months
B. Single-dose oral tinidazole plus intravaginal boric acid for 21 days
C. Treat each recurrence with a 7-day course of clindamycin cream
D. Refer to infectious disease specialist for intravenous antibiotics
Answer: A
Rationale: For recurrent BV, suppressive therapy with metronidazole gel twice weekly after initial
treatment reduces recurrence. Boric acid is used for refractory cases but not first-line. Treating
each episode alone does not prevent recurrence. IV antibiotics are not indicated.
3. A woman presents with vaginal odor and frothy yellow-green discharge. On wet mount,
motile trichomonads are seen. She has a history of metronidazole allergy (urticaria). What
is the recommended treatment?
A. Tinidazole 2 g orally single dose with desensitization if needed
B. Clindamycin 300 mg orally twice daily for 7 days
C. Metronidazole 2 g orally single dose under observation
Page 1
,D. Intravaginal paromomycin cream for 14 days
Answer: A
Rationale: Tinidazole is the alternative for trichomoniasis in metronidazole allergy, but
cross-reactivity is possible; desensitization may be needed. Clindamycin is ineffective for
trichomoniasis. Paromomycin is reserved for resistant cases. Metronidazole is contraindicated
due to allergy.
4. Which of the following best explains the mechanism by which bacterial vaginosis
increases susceptibility to HIV acquisition?
A. Reduction in vaginal Lactobacillus species leads to increased vaginal pH and loss of hydrogen
peroxide, which normally inactivates HIV
B. Anaerobic bacteria produce proteases that degrade the HIV envelope
C. BV-associated bacteria induce a robust Th1 response that recruits CD4+ T cells to the mucosa
D. Elevated pH enhances HIV reverse transcriptase activity
Answer: A
Rationale: In BV, loss of hydrogen peroxide-producing lactobacilli reduces the innate antiviral
barrier, and increased pH and biofilm facilitate HIV survival. Option C is incorrect because BV
actually reduces protective lactobacilli and may increase target cells, but the primary
mechanism is loss of hydrogen peroxide. Options B and D are not established.
5. A patient with vaginal odor has a negative wet mount and negative nucleic acid
amplification test (NAAT) for trichomonas and chlamydia/gonorrhea. She is sexually active
with a male partner who is asymptomatic. Which of the following is the most likely cause of
her symptoms?
A. Cytolytic vaginosis
B. Atrophic vaginitis
C. Desquamative inflammatory vaginitis
D. Aerobic vaginitis
Answer: D
Rationale: Aerobic vaginitis presents with vaginal odor, discharge, and inflammation, often with
negative tests for STIs and BV. It is characterized by aerobic bacteria (e.g., Group B
Streptococcus, E. coli). Cytolytic vaginosis causes burning and dyspareunia, not odor. Atrophic
vaginitis occurs with estrogen deficiency. Desquamative inflammatory vaginitis is a severe form
of aerobic vaginitis but less common.
6. In a patient with persistent vaginal odor despite multiple courses of antibiotics, which of
the following diagnostic tests is most appropriate to evaluate for non-infectious causes?
A. Vaginal biopsy for histology
B. High-resolution anoscopy
C. Colposcopy with acetic acid
Page 2
,D. MRI of the pelvis
Answer: A
Rationale: Vaginal biopsy can diagnose conditions like desquamative inflammatory vaginitis,
lichen planus, or malignancy. High-resolution anoscopy is for anal lesions. Colposcopy is for
cervical evaluation. MRI is not indicated for vaginal odor without other findings.
7. A woman with recurrent BV is interested in probiotic prophylaxis. Based on 2026
evidence, which statement about probiotics is most accurate?
A. Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 have demonstrated efficacy in
reducing BV recurrence when used as adjunct to antibiotics
B. Probiotics are contraindicated in immunocompetent women due to risk of bacteremia
C. Intravaginal probiotic suppositories are superior to oral probiotics for preventing BV recurrence
D. Probiotics alone are as effective as metronidazole for treatment of acute BV
Answer: A
Rationale: Evidence supports oral Lactobacillus strains GR-1 and RC-14 as adjuncts to reduce
BV recurrence. Option B is false; probiotics are safe in immunocompetent women. Option C: no
clear superiority of intravaginal over oral. Option D: probiotics are not recommended as
monotherapy for acute BV.
8. A 25-year-old woman with vaginal odor and discharge is found to have bacterial
vaginosis on wet mount. She is currently taking oral contraceptives. Which of the following
is true regarding the interaction between BV treatment and her contraception?
A. Metronidazole may reduce the efficacy of oral contraceptives, requiring backup contraception
B. Clindamycin cream may weaken latex condoms, but not oral contraceptives
C. Tinidazole has no effect on oral contraceptive metabolism
D. Antibiotics for BV do not affect oral contraceptive efficacy, with the exception of rifampin
Answer: D
Rationale: Current evidence indicates that most antibiotics, including metronidazole and
clindamycin, do not reduce oral contraceptive efficacy. Rifampin is the only antibiotic known to
induce hepatic enzymes and reduce efficacy. Options A and C are incorrect. Option B is true for
oil-based vaginal products but not specifically for clindamycin cream.
9. In the management of trichomoniasis, which of the following is a recommended step to
ensure partner treatment and reduce reinfection?
A. Expedited partner therapy (EPT) with a prescription for the partner without examination
B. Require partner to be examined and treated by a clinician
C. Advise patient to abstain from sex until both partners are treated, but no partner treatment is
necessary if asymptomatic
D. Treat only the patient and recommend partner testing only if symptoms develop
Answer: A
Page 3
, Rationale: Expedited partner therapy (EPT) is recommended for trichomoniasis to reduce reinfection rates. Option B is not
required; EPT is effective. Option C is incorrect because asymptomatic male partners often carry the infection. Option D
leads to high reinfection risk.
10. A patient with vaginal odor has a positive NAAT for Trichomonas vaginalis. She is
pregnant (first trimester). What is the recommended treatment?
A. Metronidazole 2 g orally single dose (avoid in first trimester)
B. Tinidazole 2 g orally single dose (preferred in pregnancy)
C. Clindamycin 300 mg orally twice daily for 7 days
D. Metronidazole 500 mg orally twice daily for 7 days
Answer: D
Rationale: The 2026 CDC recommends metronidazole 500 mg BID for 7 days for trichomoniasis
in pregnancy, even in first trimester, as it is safe. Option A is incorrect because single-dose
metronidazole is less effective. Tinidazole is not recommended in pregnancy. Clindamycin is
ineffective for trichomoniasis.
11. A 30-year-old woman with no significant medical history presents with a 3-day history
of malodorous vaginal discharge, pruritus, and burning on urination. She is sexually active
with one male partner and uses condoms inconsistently. On speculum exam, there is a thin,
homogeneous, gray-white discharge with a fishy odor. A wet mount shows clue cells. Which
of the following pathophysiological mechanisms is most directly responsible for the
characteristic odor in this condition?
A. Overgrowth of Lactobacillus species producing excess lactic acid
B. Production of polyamines by anaerobic bacteria such as Gardnerella vaginalis
C. Release of prostaglandins from disrupted epithelial cells
D. Activation of histamine release from mast cells in the vaginal mucosa
Answer: B
Rationale: The fishy odor in bacterial vaginosis (BV) is due to the production of polyamines (e.g.,
putrescine, cadaverine) by anaerobic bacteria, which become volatile when alkalinized (e.g., by
the KOH whiff test). Option A is incorrect because Lactobacillus normally produces lactic acid,
which is protective, and its decrease is associated with BV. Option C is associated with
prostaglandins in menstruation, not odor. Option D describes an allergic or inflammatory
response, not characteristic of BV.
12. A 25-year-old woman with recurrent bacterial vaginosis (BV) is considering long-term
suppressive therapy. She has had three episodes in the past year. According to the 2021
CDC STI Treatment Guidelines, which of the following regimens is recommended for
suppressive therapy in women with recurrent BV?
A. Metronidazole vaginal gel 0.75% once weekly for 4 months
B. Metronidazole 500 mg orally twice daily for 7 days each month
C. Clindamycin ovules 100 mg intravaginally once daily for 10 days
Page 4
